Global Hyaluronidase Market Size Expected to Acquire USD 1.32 Billion by 2030, Grow at 9.01% CAGR

Portland, OR, April 11, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Hyaluronidase Market By Type (Animal-Derived Hyaluronidase And Synthetic Hyaluronidase), By Application (Chemotherapy, Dermatology, Ophthalmology, Plastic Surgery, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts, 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Hyaluronidase Market size & share in terms of revenue was valued at USD 863.12 million in 2022 and it is expected to surpass around USD 1.32 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 9.01% during the forecast period 2023 to 2030.”

What is Hyaluronidase? How big is the Hyaluronidase Industry?

Report Overview:

The global hyaluronidase market size was valued at USD 863.12 Million in 2022 and is expected to reach USD 1,326.9 Million by 2030, growing at a compound annual growth rate (CAGR) of 9.01% during the forecast period.

Hyaluronidase is an enzyme that breaks down hyaluronic acid, a natural substance found in the body's connective tissues. It is a versatile enzyme that is used in various medical and cosmetic applications. The enzyme is primarily used as an adjuvant in anesthesia and to improve the absorption and dispersion of drugs. It is also used in the treatment of medical conditions such as cancer, ophthalmology, and in surgical procedures. In the cosmetic industry, hyaluronidase is used to reduce swelling and bruising associated with injectable fillers and to reverse the effects of overfilling.

Hyaluronidase is generally well-tolerated, but some patients may experience adverse effects such as allergic reactions, including anaphylaxis. As a result, it should be used with caution, and patients should be monitored closely for any adverse reactions. The regulatory landscape for hyaluronidase varies across countries, and some countries have strict regulations regarding its use. Thus, hyaluronidase has proven to be a useful enzyme in various applications, and ongoing research is likely to uncover even more uses for this versatile enzyme.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs -https://www.zionmarketresearch.com/sample/hyaluronidase-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

• Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
• The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
• About 198+ Pages Research Report (Including Recent Research)
• Provide detailed chapter-by-chapter guidance on Request
• Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
• Includes Tables and figures have been updated
• The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
• Zion Market Research research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global Hyaluronidase Market: Growth Factors

The global hyaluronidase market is driven by several factors, including the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, and growing awareness of hyaluronidase applications in the pharmaceutical & cosmetic industries. Technological advancements in drug delivery systems and the availability of funding for research & development activities are creating new opportunities for the market. However, the market also faces challenges such as the high cost of treatment, adverse side effects, and strict regulations regarding the use of hyaluronidase. The limited availability of skilled professionals trained in administering hyaluronidase and the risk of infections associated with its use may also pose challenges. Despite these restraints, the increasing adoption of hyaluronidase in developing countries and the development of biosimilars are expected to create new growth opportunities for the market in the future.

Directly Purchase a copy of the report with TOC @ buynowURL

Report Scope

Hyaluronidase Market: Segmentation Analysis

The global hyaluronidase market is segmented into type, application, and region.

Based on type, the market is bifurcated into animal-derived hyaluronidase and synthetic hyaluronidase. The animal-derived hyaluronidase segment held the largest market share in 2022 and is further predicted to cite a notable CAGR during the forecast period. The animal-derived hyaluronidase segment of the market is expected to experience steady growth due to the increasing demand for hyaluronidase in animal husbandry and veterinary medicine. Animal-derived hyaluronidase is commonly used to improve the effectiveness of vaccines, particularly in poultry and swine industries, and as a wound-healing agent in veterinary medicine. In addition, animal-derived hyaluronidase is used in various research and development activities in the pharmaceutical and biotechnology industries. The animal-derived hyaluronidase segment is also expected to benefit from the growing trend toward the use of natural and organic products in the cosmetic industry. Animal-derived hyaluronidase is used as an ingredient in skincare products, particularly in anti-aging products, due to its ability to stimulate collagen production and improve skin hydration.

Based on application, the hyaluronidase industry is segmented into chemotherapy, dermatology, ophthalmology, plastic surgery, and others. The dermatology segment held a dominating market share in 2022 and is further projected to cite a notable CAGR during the forecast period. The dermatology segment of the hyaluronidase market is expected to experience significant growth due to the rising demand for injectable dermal fillers and the increasing popularity of minimally invasive cosmetic procedures.

Hyaluronidase is used in dermatology to quickly dissolve hyaluronic acid-based dermal fillers, which are commonly used to treat wrinkles, fine lines, and volume loss. The increasing prevalence of skin-related conditions, such as acne and rosacea, is also expected to drive the demand for hyaluronidase in dermatology. Hyaluronidase is used as a treatment for these conditions, as it can help to reduce inflammation and promote wound healing. The dermatology segment is expected to benefit from the growing trend toward natural and organic skincare products. Hyaluronidase is increasingly being used as an ingredient in these products, as it has been shown to stimulate collagen production and improve skin hydration.

The global Hyaluronidase market is segmented as follows:

By Type

• Animal-Derived Hyaluronidase
• Synthetic Hyaluronidase

By Application

• Chemotherapy
• Dermatology
• Ophthalmology
• Plastic Surgery

Browse the full “Hyaluronidase Market By Type (Animal-Derived Hyaluronidase and Synthetic Hyaluronidase), By Application (Chemotherapy, Dermatology, Ophthalmology, Plastic Surgery, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2023 – 2030.”- Report at https://www.zionmarketresearch.com/report/hyaluronidase-market

Competitive Landscape

Some of the main competitors dominating the global Hyaluronidase market include - 

• Baxter International Inc.
• Halozyme Therapeutics Inc.
• Pfizer Inc.
• Shire Plc
• F. Hoffmann-La Roche Ltd.
• Sandoz International GmbH
• Quidel Corporation
• CSL Limited
• Pharming Group NV
• IBSA Institut Biochimique SA
• Fresenius Kabi AG
• Johnson & Johnson
• Nordic Group BV
• Bausch Health Companies Inc.
• AstraZeneca
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Santen Pharmaceutical Co. Ltd.
• Sanofi SA.

 Key Insights from Primary Research:

• According to the analysis shared by our research forecaster, the Hyaluronidase market is likely to expand at a CAGR of around 9.01% during the forecast period (2023-2030).                                            
• In terms of revenue, the Hyaluronidase market size was valued at around US$ 863.12 million in 2022 and is projected to reach US$ 1.32 billion by 2030.
• Based on type, the animal-derived hyaluronidase segment held the dominating market share in 2022.
• Based on application, the dermatology segment held a notable market share in 2022.
• Based on region, the North American region held the largest market share in 2022.

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/hyaluronidase-market

Key questions answered in this report:

• What is the market size and growth rate forecast for Hyaluronidase industry?
• What are the main driving factors propelling the Hyaluronidase Market forward?
• What are the leading companies in the Hyaluronidase Industry?
• What segments does the Hyaluronidase Market cover?
• How can I receive a free copy of the Hyaluronidase Market sample report and company profiles?

Key Offerings:

• Market Size & Forecast by Revenue | 2023−2030
• Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
• Market Segmentation – A detailed analysis By Type, By Application, And By Region
• Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/5691

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

The North American region held the largest hyaluronidase market share in 2022 and is further predicted to grow rapidly at a significant CAGR during the forecast period. This is mainly due to the increasing demand for hyaluronidase in various medical and cosmetic applications. The rising prevalence of skin-related conditions such as acne, rosacea, and wrinkles has resulted in the increased adoption of hyaluronidase in dermatology. Moreover, the growing geriatric population in North America is also expected to drive the demand for hyaluronidase, particularly in the treatment of age-related conditions such as osteoarthritis.

The increasing prevalence of chronic diseases such as cancer and diabetes is also expected to boost the demand for hyaluronidase as an adjuvant therapy to improve drug delivery. North America is a prominent market for cosmetic procedures, and hyaluronidase is increasingly being used as a treatment for overfilled areas or unwanted lumps resulting from dermal filler injections. The availability of advanced healthcare infrastructure, higher disposable income, and the presence of key market players in the region are some of the factors contributing to the growth of the hyaluronidase market in North America.

By Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • France
  • UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Recent Developments

• In August 2021, Halozyme Therapeutics, Inc. announced the initiation of Phase 3 clinical trial for its investigational drug, PEGPH20, in combination with chemotherapy in patients with previously untreated metastatic pancreatic cancer. PEGPH20 is a pegylated recombinant human hyaluronidase that targets the extracellular matrix of tumors to improve the delivery of chemotherapy.
• In July 2021, Shire, a subsidiary of Takeda Pharmaceutical Company Limited, received FDA approval for its investigational enzyme replacement therapy, HyQvia, for the treatment of primary immunodeficiency. HyQvia contains recombinant human hyaluronidase and is administered subcutaneously to improve the absorption and distribution of immunoglobulin.
• In June 2021, Abbott announced the launch of its Alinity m system, a molecular diagnostic instrument that offers a broad range of infectious disease testing capabilities. The instrument features the company's proprietary hyaluronidase pretreatment technology, which is designed to enhance the extraction of DNA and RNA from samples.

To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/hyaluronidase-market

Browse Other Related Research Reports from Zion Market Research:

Viral Vectors and Plasmid DNA Manufacturing Market by Product Type (Viral Vectors (Retrovirus, Lentiviruses, Adenoviruses, Adeno-Associated Viruses, and Others) and Plasmid (DNA Conjugative Plasmids, and Non-Conjugative Plasmids)), by Application (Gene and Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, and Others), and by End-User (Biotechnology Companies, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026: https://www.zionmarketresearch.com/report/viral-vectors-and-plasmid-dna-manufacturing-market

Primary Cells Market by Origin (Hematopoietic Cells, Renal Cells, Skin Cells, Lung Cells, Gastrointestinal Cells, Heart, Liver Cells, Skeletal and Muscle Cells, and Other Primary Cells), by Type (Human Primary Cells and Animal Primary Cells), and by End-User (Life Science Research Companies and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024: https://www.zionmarketresearch.com/report/primary-cells-market

Animal Genetics Market: by Product (Live Animals (Porcine, Poultry, Canine, Bovine, and Others) and Genetic Material (Embryo and Semen)) and by Service (Genetic Disease Tests, Genetic Trait Tests, DNA Typing, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024: https://www.zionmarketresearch.com/report/animal-genetics-market

Oligonucleotide Synthesis Market by Offering (Equipment, Reagents and Consumables, and Synthesized Oligonucleotides [Product and Services), by Application (Research, Therapeutics, and Diagnostics), and by End-User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026: https://www.zionmarketresearch.com/report/oligonucleotide-synthesis-market

Protein Engineering Market by Product Type (Instruments, Reagents, and Services & Software), by Technology (Rational Protein Design and Irrational Protein Design), by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Growth Hormones, Coagulation Factor, Vaccines, and Others), and by End-User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Contract Research Organizations): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2024: https://www.zionmarketresearch.com/report/protein-engineering-market

Bioburden Testing Market by Product Type (Instrument and Consumables), by Test Type (Anaerobic, Aerobic, Spore, and Fungi), by Application (Sterility Testing, Medical Devices, and Raw Material), and by End-User (Biotechnology, Pharma, and CMO): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/bioburden-testing-market

Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/genotyping-assay-market

Aseptic Sampling Market by Type (Manual Aseptic Sampling and Automated Aseptic Sampling), by Technique (Off-Line Sampling, At-Line Sampling, and On-Line Sampling), by Application (Upstream Process and Downstream Process), and by End-User (Biotechnology and Pharmaceutical Manufacturers, Contract Research and Manufacturing Organizations, Research and Development Departments, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/aseptic-sampling-market

Proteomics Market by Component (Reagents and Instruments) and by Application (Disease Diagnosis, Drug Discovery, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/proteomics-market

Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/cell-viability-assays-market

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch

Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/

Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 7768 006 007

Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information: sales@zionmarketresearch.com